Novel chromenone potassium channel blockers and uses thereof

Details for Australian Patent Application No. 2007304881 (hide)

Owner Bionomics Limited

Inventors Flynn, Bernard Luke; Mould, Jorgen Alvar; Paul, Dharam; Chaplin, Jason Hugh; Harvey, Andrew J.; Baell, Jonathan B.

Agent Davies Collison Cave

Pub. Number AU-A-2007304881

PCT Pub. Number WO2008/040058

Priority 60/849,256 04.10.06 US

Filing date 4 October 2007

Wipo publication date 10 April 2008

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/015 (2006.01)

A61K 31/353 (2006.01)

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61K 31/4355 (2006.01)

A61K 31/436 (2006.01)

Event Publications

2 April 2009 PCT application entered the National Phase

  PCT publication WO2008/040058 Priority application(s): WO2008/040058

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007304883-VLP based vaccine delivery system

2007304880-Novel benzofuran potassium channel blockers and uses thereof